Journal of the Association of Nurses in AIDS Care
Volume 18, Issue 4 , Pages 32-40 , July 2007

Distal Sensory Polyneuropathy in the Context of HIV/AIDS

References 

  1. Agnoletto V, Chiaffarino F, Nasta P, Rossi R, Parazzini F. Reasons for complementary therapies and characteristics of use among HIV-infected people. International Journal of STD and AIDS. 2003;14:482–486
  2. Backonja M. Use of anticonvulsants for treatment of neuropathic pain. Neurology. 2002;59:S14–S17
  3. Bartlett JG, Gallant JE. 2005-2006 Medical management of HIV infection. Baltimore, MD: Johns Hopkins Medicine Health Publishing Business Group; 2005;
  4. Brew BJ. The peripheral nerve complications of HIV infection. Muscle & Nerve. 2003;28:542–552
  5. Brew BJ, Tisch S, Law M. Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy. AIDS. 2003;17:1094–1096
  6. Brinley FJ, Pardo CA, Verma A. Human immunodeficiency virus and the peripheral nervous system workshop. Archives of Neurology. 2001;58:1561–1566
  7. Cherry CL, Skolasky RL, Lal L, Creighton J, Hauer P, Raman SP, et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology. 2006;66:867–873
  8. Delakas MC. Peripheral neuropathy and antiretroviral drugs. Journal of the Peripheral Nervous System. 2001;6:14–20
  9. Dieterich DT. Long-term complications of nucleoside reverse transcriptase inhibitor therapy. AIDS Reader. 2003;13:176–184
  10. Dorsey SG, Morton PG. HIV peripheral neuropathy: Pathophysiology and clinical implications. AACN Clinical Issues. 2006;17:30–36
  11. Estanislao L, Carter K, McArthur J, Olney R, Simpson D Lidoderm HIV Neuropathy Group. A randomized controlled trial of 5% Lidocaine gel for HIV associated distal symmetric polyneuropathy. Journal of Acquired Immune Deficiency Syndrome. 2004;37:1584–1586
  12. Ferrari S, Vento S, Monaco S, Cavallaro T, Cainelli F, Rizzuto N, et al. Human immunodeficiency virus–associated peripheral neuropathies. Mayo Clinic Proceedings. 2006;81:213–219
  13. Gondim Fde A, Thomas FP. Editorial comment: Diagnostic challenges of distal sensory polyneuropathy in HIV-infected persons. AIDS Reader. 2005;15:349
  14. Grond S, Zech D, Schug SA, Lynch J, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. Journal of Pain and Symptom Management. 1991;6:411–422
  15. Hahn K, Arendt G, Braun JS, von Giesen HJ, Husstedt IW, Maschke M, et al. German Neuro-AIDS Working Group A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. Journal of Neurology. 2004;251:1260–1266
  16. Herrmann DN, McDermott MP, Sowden JE, Henderson D, Messing S, Cruttenden K, et al. Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? (A longitudinal study). Neurology. 2006;66:857–861
  17. Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, Shafer RW, et al. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: An adult AIDS clinical trials group study. AIDS. 2005;19:1341–1349
  18. Keswani S, Pardo C, Cherry C, Hoke A, McArthur JC. HIV-associated sensory neuropathies. AIDS. 2002;16:2105–2117
  19. Kieburtz K, Simpson D, Yiannoutsos C, Max MB, Hall CD, Ellis RJ, et al. AIDS Clinical Trial Group 242 Protocol Team A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology. 1998;51:1682–1688
  20. Lichtenstein KA, Armon C, Baron A, Moorman AC, Wood KC, Holmberg SD. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clinical Infectious Diseases. 2005;40:148–157
  21. Luciano CA, Pardo CA, McArthur JC. Recent developments in the HIV neuropathies. Current Opinions in Neurology. 2003;16:403–409
  22. Melli G, Keswani SC, Fischer A, Chen W, Hoke A. Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain. 2006;129:1330–1338Epub. Retrieved April 12, 2007, from http://brain.oxfordjournals.org
  23. Mills E, Wu P, Ernst E. Complementary therapies for the treatment of HIV: In search of the evidence. International Journal of STD and AIDS. 2005;16:395–403
  24. Morgello S, Estanislao L, Simpson D, Geraci A, DiRocco A, Gerits P, et al. Manhattan HIV Brain Bank HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: The Manhattan HIV Brain Bank. Archives of Neurology. 2004;61:546–551
  25. Nicholas PK, Kemppainen JK, Canaval GE, Corless IB, Sefcik EF, Nokes KM, et al. Symptom management and self-care for peripheral neuropathy in HIV/AIDS. AIDS Care. 2007;19:179–189
  26. Nicholas PK, Kemppainen JK, Holzemer WL, Nokes KM, Eller LS, Corless IB, et al. Self-care management for neuropathy in HIV disease. AIDS Care. 2002;14:763–771
  27. Osio M, Muscia R, Zampini L, Nascimbene C, Mailland E, Cargnel A, et al. Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency patients: an open label study. Journal of the Peripheral Nervous System. 2006;11:72–76
  28. Osio M, Zampini L, Muscia F, Valsechi L, Comi C, Cargnel A, et al. Cutaneous silent period in human immunodeficiency virus-related peripheral neuropathy. Journal of the Peripheral Nervous System. 2004;9:224–231
  29. Pardo CA, McArthur JC, Griffin JW. HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease. Journal of the Peripheral Nervous System. 2001;6:21–27
  30. Phillips KD, Skelton WD, Hand GA. Effect of acupuncture administered in a group setting on pain and subjective peripheral neuropathy in persons with human immunodeficiency virus disease. Journal of Alternative and Complementary Medicine. 2004;10:449–455
  31. Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, Epstein L, et al. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders (Incidence of and risk factors for HIV-associated distal sensory polyneuropathy). Neurology. 2002;58:1764–1768
  32. Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, McClernon DR, et al. NEAD Consortium Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology. 2005;64:842–848
  33. Simpson DM. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. Journal of Neurovirology. 2002;8:33–41
  34. Simpson, D. M., & Cikurel, K. (2006). Neurologic and psychiatric adverse effects of antiretroviral agents. In Neurologic aspects of HIV/AIDS: New insights and management advances. Retrieved August 28, 2006, from http://www.clinicaloptions.com/neuroaids
  35. Simpson DM, Kitch D, Evans SR, McArthur JC, Asmuth DM, Cohen B, et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology. 2006;66:1679–1687
  36. Simpson DM, McArthur JC, Olney R, Clifford D, So Y, Ross D, et al. Lamotrigine for HIV-associated painful sensory neuropathies. Neurology. 2003;60:1508–1514
  37. Simpson DM, Olney R, McArthur JC, Khan A, Godold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neuropathy. 2000;54:2115–2119
  38. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Annals of Internal Medicine. 1994;121:769–785
  39. Skopelitis EE, Kikotis PI, Kontos AN, Panayiotakopoulos GD, Konstantinou K, Kordossis T, et al. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: An entity underestimated by clinical examination. International Journal of STD & AIDS. 2006;17:467–472
  40. Swanson B, Zeller JM, Paice JA. HIV-associated distal symmetrical polyneuropathy: Clinical features and nursing management. Journal of the Association of Nurses in AIDS Care. 1998;9:77–80
  41. Verma S, Estanislao L, Mintz L, Simpson D. Controlling neuropathic pain in HIV. Current HIV/AIDS Reports. 2004;1:136–141
  42. Verma S, Estanislao L, Simpson D. HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs. 2005;19:325–334
  43. Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology, and treatment. Drugs. 2000;59:1251–1260
  44. Zanetti C, Manzano G, Gabbai A. The frequency of peripheral neuropathy in a group of HIV positive patients in Brazil. Archives of Neuro-Psychiatry. 2004;62:1–9

PII: S1055-3290(07)00124-0

doi: 10.1016/j.jana.2007.05.003

Journal of the Association of Nurses in AIDS Care
Volume 18, Issue 4 , Pages 32-40 , July 2007

Article Tools

* Image Usage & Resolution